News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
872,767 Results
Type
Article (88151)
Company Profile (825)
Press Release (783772)
Multimedia
Podcasts (205)
Webinars (30)
Section
Business (233341)
Career Advice (4152)
Deals (39893)
Drug Delivery (155)
Drug Development (91470)
Employer Resources (205)
FDA (18424)
Job Trends (17439)
News (398097)
Policy (39990)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3023)
Academic (2)
Accelerated approval (38)
Adcomms (36)
Allergies (161)
Alliances (56982)
ALS (188)
Alzheimer's disease (1824)
Antibody-drug conjugate (ADC) (371)
Approvals (18623)
Artificial intelligence (671)
Autoimmune disease (188)
Automation (46)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (490)
Bladder cancer (170)
Brain cancer (68)
Breast cancer (692)
Cancer (5277)
Cardiovascular disease (467)
Career advice (3577)
Career pathing (43)
CAR-T (317)
CDC (66)
Celiac Disease (2)
Cell therapy (868)
Cervical cancer (39)
Clinical research (77328)
Collaboration (1925)
Company closure (5)
Compensation (1221)
Complete response letters (78)
COVID-19 (3002)
CRISPR (106)
C-suite (950)
Cystic fibrosis (155)
Data (6585)
Decentralized trials (2)
Denatured (75)
Depression (160)
Diabetes (552)
Diagnostics (7308)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (328)
Drug pricing (230)
Drug shortages (36)
Duchenne muscular dystrophy (255)
Earnings (100611)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135708)
Executive appointments (1067)
FDA (21767)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1628)
Gene editing (227)
Generative AI (71)
Gene therapy (705)
GLP-1 (1162)
Government (5474)
Grass and pollen (8)
Guidances (389)
Healthcare (20977)
HIV (75)
Huntington's disease (53)
IgA nephropathy (89)
Immunology and inflammation (307)
Immuno-oncology (74)
Indications (126)
Infectious disease (3316)
Inflammatory bowel disease (216)
Inflation Reduction Act (17)
Influenza (131)
Intellectual property (267)
Interviews (817)
IPO (17969)
IRA (61)
Job creations (5202)
Job search strategy (2867)
JPM (72)
Kidney cancer (19)
Labor market (98)
Layoffs (662)
Leadership (43)
Legal (10166)
Liver cancer (100)
Longevity (19)
Lung cancer (710)
Lymphoma (393)
Machine learning (46)
Management (66)
Manufacturing (914)
MASH (180)
Medical device (15084)
Medtech (15148)
Mergers & acquisitions (23026)
Metabolic disorders (1465)
mRNA (200)
Multiple sclerosis (176)
NASH (23)
Neurodegenerative disease (379)
Neuropsychiatric disorders (108)
Neuroscience (3228)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5120)
Now hiring (70)
Obesity (715)
Opinion (347)
Ovarian cancer (173)
Pain (224)
Pancreatic cancer (248)
Parkinson's disease (315)
Partnered (39)
Patents (542)
Patient recruitment (541)
Peanut (64)
People (67116)
Pharmaceutical (145)
Pharmacy benefit managers (34)
Phase 1 (23894)
Phase 2 (33554)
Phase 3 (25272)
Pipeline (5864)
Policy (353)
Postmarket research (3554)
Preclinical (10720)
Press Release (72)
Prostate cancer (267)
Psychedelics (60)
Radiopharmaceuticals (316)
Rare diseases (986)
Real estate (7444)
Recruiting (81)
Regulatory (29297)
Reports (69)
Research institute (2740)
Resumes & cover letters (653)
Rett syndrome (28)
RNA editing (21)
RSV (90)
Schizophrenia (165)
Series A (273)
Series B (206)
Service/supplier (30)
Sickle cell disease (109)
Special edition (28)
Spinal muscular atrophy (178)
Sponsored (49)
Startups (4339)
State (2)
Stomach cancer (21)
Supply chain (116)
Tariffs (101)
The Weekly (128)
Vaccines (1186)
Venture capital (101)
Weight loss (491)
Women's health (102)
Worklife (23)
Date
Today (197)
Last 7 days (889)
Last 30 days (3000)
Last 365 days (32870)
2026 (5080)
2025 (33228)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (352)
Arkansas (15)
Asia (51670)
Australia (9078)
California (12082)
Canada (3442)
China (1219)
Colorado (508)
Connecticut (525)
Delaware (360)
Europe (118866)
Florida (1796)
Georgia (389)
Hawaii (4)
Idaho (68)
Illinois (1008)
India (79)
Indiana (569)
Iowa (24)
Japan (460)
Kansas (135)
Kentucky (46)
Louisiana (31)
Maine (84)
Maryland (1504)
Massachusetts (8846)
Michigan (375)
Minnesota (681)
Mississippi (6)
Missouri (144)
Montana (36)
Nebraska (30)
Nevada (132)
New Hampshire (88)
New Jersey (3237)
New Mexico (33)
New York (3181)
North Carolina (1669)
North Dakota (10)
Northern California (5845)
Ohio (375)
Oklahoma (23)
Oregon (55)
Pennsylvania (2410)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (70)
South Dakota (1)
Southern California (4668)
Tennessee (185)
Texas (1901)
United States (43461)
Utah (366)
Vermont (1)
Virginia (304)
Washington D.C. (88)
Washington State (1004)
West Virginia (4)
Wisconsin (138)
Wyoming (2)
There are 872,767 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SystImmune and Bristol Myers Squibb Highlight Positive Phase III Interim Topline Results for izalontamab brengitecan (Iza-bren) in Previously Treated Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer
February 26, 2026
·
7 min read
Press Releases
Compass Pathways Announces Exercise of $200 Million in Outstanding Warrants
February 26, 2026
·
4 min read
Press Releases
Lilly’s oral GLP-1, orforglipron, delivered superior blood sugar control and weight loss compared to oral semaglutide in head-to-head type 2 diabetes trial published in The Lancet
February 26, 2026
·
10 min read
Press Releases
Perrigo Reports Fourth Quarter and Fiscal Year 2025 Financial Results From Continuing Operations
February 26, 2026
·
71 min read
Press Releases
Aveanna Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call
February 26, 2026
·
1 min read
Press Releases
Update: Enovis Announces Fourth Quarter and Full Year 2025 Results
February 26, 2026
·
28 min read
Press Releases
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
February 26, 2026
·
11 min read
Press Releases
Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress
February 26, 2026
·
9 min read
Press Releases
BeOne Medicines Announces Fourth Quarter and Full Year 2025 Financial Results, Highlighting Global Success of BRUKINSA and Foundational Oncology Leadership
February 26, 2026
·
23 min read
Press Releases
IRLAB Secures Milestone Payment for First Patient Dosed in Phase Ib Study with IRL757 in Parkinson’s Disease
February 26, 2026
·
4 min read
1 of 87,277
Next
